within the rapidly evolving field of oncology exploration, correct and productive mutation screening is vital for establishing focused therapies. The KRAS solutions System plays a pivotal function With this landscape by supplying comprehensive solutions for KRAS mutation profiling and Evaluation. KRAS mutations, found in about 95% of RAS-relevant o